Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Pharmaceutical Retailersβ
2026-06-08HKPD3Director Mike Yao Zhou Reports No Securities Ownership in Cellyan Biotechnology Co., Ltd
This Form 3 filing reports that Mike Yao Zhou, a director of Cellyan Biotechnology Co., Ltd (ticker: HKPD), filed a statement of beneficial ownership indicating he holds no securities in the company as of March 18, 2026. The filing was signed on June 2, 2026, and confirms Zhou's position as a director but not as an off...
Nano CapPharmaceutical Retailers
2026-06-08HKPD3Form 3 Filing: Shu Liu Reports No Securities Ownership in Cellyan Biotechnology Co., Ltd
This is a Form 3 initial statement of beneficial ownership of securities filed by Shu Liu, who serves as CFO of Cellyan Biotechnology Co., Ltd (ticker: HKPD). The filing reports that as of March 18, 2026, Liu Shu holds no securities in the company. The filing was signed on June 2, 2026, and indicates that the reporting...
Nano CapPharmaceutical Retailers
2026-06-08HKPD3Insider Filing - Cellyan Biotechnology Co., Ltd (HKPD)
This filing reports on a change in beneficial ownership for Cellyan Biotechnology Co., Ltd (HKPD). The reporting owner, Liang Chenyu Andy, identified by CIK 0002125293, holds the position of CEO and Director at the company. The filing indicates that the owner has no securities owned, with a reporting date of March 18, ...
Nano CapPharmaceutical Retailers
2026-06-08Cellyan Biotechnology Co., Ltd3Form 3 Filing: Shu Liu Reports No Securities Ownership in Cellyan Biotechnology Co., LtdDuplicate
This is a Form 3 initial statement of beneficial ownership of securities filed by Shu Liu, who serves as CFO of Cellyan Biotechnology Co., Ltd (ticker: HKPD). The filing reports that as of March 18, 2026, Liu Shu holds no securities in the company. The filing was signed on June 2, 2026, and indicates that the reporting...
Nano CapPharmaceutical Retailers